Skip to main content

(Approval lapsed) Piperacillin/Tazobactam 4 g/0.5 g Powder for Solution for Infusion (Wockhardt)

Section 19A approved medicine
(Approval lapsed) Piperacillin/Tazobactam 4 g/0.5 g Powder for Solution for Infusion (Wockhardt)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
PIPERTAZ SANDOZ 4 g/ 0.5 g piperacillin (as sodium) 4g and tazobactam (as sodium) 0.5 g powder for injection bottle - ARTG 140840
Indication(s)

Piperacillin/Tazobactam is indicated for the treatment of the following infections:

  1. Lower respiratory tract infections;
  2. Complicated Urinary tract infections;
  3. Intra-abdominal infections;
  4. Skin and skin structure infections;
  5. Bacterial septicaemia.

In hospitalised children aged 2 to 12 years, it is indicated for the treatment of serious intra-abdominal infections.

Help us improve the Therapeutic Goods Administration site